Theranostic
agents development within reach

RPO Group is a radiotheranostic CRO located in Europe, an area of world-leading innovation in radiomolecular precision oncology. A collaborative alliance of experts including Prof Dr Richard P Baum, Prof Dr Andreas Türler, and Dr Hugo M L Jansen unites their respective specialities enabling a tailor-made approach.

About us
Clinical study management
Our focus is on providing clinical trial services for your radiotheranostic compounds in early development.
Radiomolecular image management
Explore our specialized capabilities in radiomolecular image management, including harmonized acquisition requirements and bespoke analysis, complemented by comprehensive training and support.
Scientific & Medical consultancy services
World-leading KOLs in radiotheranostics are on hand to advise you and support the advancement of your pipeline at every step of your clinical development pathway.
Medical Writing
Our medical and clinical research experts can provide a full suite of documents from a protocol synopsis to final clinical study report.

The Latest

blog
RPO Group flyer
Download our flyer to get to know RPO Group in a nutshell.
Read more
blog
Theranostics explained
Download our infographic to see how Theranostics can tailor treatment to your unique health profile, enhancing effectiveness and minimizing side effects.
Read more
blog
Visit us on the 5th Targeted Radiopharmaceuticals Summit Europe
RPO Group will have a booth on the 5th Targeted Radiopharmaceuticals Summit Europe.
Read more
Privacy Policy Website Disclaimer Cookie Policy